FRANCO, Renato
 Distribuzione geografica
Continente #
EU - Europa 6.084
NA - Nord America 5.073
AS - Asia 989
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 7
OC - Oceania 4
Totale 12.180
Nazione #
US - Stati Uniti d'America 4.959
IE - Irlanda 2.174
UA - Ucraina 893
IT - Italia 884
GB - Regno Unito 745
SG - Singapore 357
DE - Germania 348
CN - Cina 342
FR - Francia 314
GR - Grecia 250
FI - Finlandia 233
TR - Turchia 227
SE - Svezia 147
CA - Canada 110
BE - Belgio 31
VN - Vietnam 18
PK - Pakistan 13
ES - Italia 11
RS - Serbia 11
EU - Europa 10
NL - Olanda 10
MK - Macedonia 8
CZ - Repubblica Ceca 7
PH - Filippine 7
TW - Taiwan 7
CH - Svizzera 6
BJ - Benin 5
DZ - Algeria 5
IN - India 5
IR - Iran 5
AU - Australia 4
AR - Argentina 3
KR - Corea 3
MX - Messico 3
PL - Polonia 3
AT - Austria 2
BG - Bulgaria 2
BR - Brasile 2
IL - Israele 2
MA - Marocco 2
PE - Perù 2
RU - Federazione Russa 2
DK - Danimarca 1
ID - Indonesia 1
JP - Giappone 1
MY - Malesia 1
NO - Norvegia 1
PT - Portogallo 1
SV - El Salvador 1
ZA - Sudafrica 1
Totale 12.180
Città #
Dublin 2.162
Jacksonville 1.368
Chandler 817
Princeton 330
Roxbury 287
Medford 255
Singapore 193
Wilmington 161
Bremen 134
Beijing 130
Ann Arbor 124
Caserta 109
Des Moines 104
Naples 103
Elora 99
Woodbridge 87
Cambridge 79
Boardman 78
New York 78
Napoli 62
San Mateo 56
Ashburn 54
Nanjing 42
Düsseldorf 40
Mountain View 40
Brussels 30
Houston 26
Jinan 22
Pozzuoli 21
Dong Ket 18
Nanchang 18
Auburn Hills 17
Norwalk 17
Rome 16
Milan 15
Montesarchio 15
Redwood City 15
Shenyang 15
Falls Church 14
Helsinki 14
Kunming 14
Tianjin 14
Munich 13
Seattle 13
Aversa 11
London 11
Venice 11
Belgrade 10
Lappeenranta 9
Los Angeles 9
Guangzhou 8
Zhengzhou 8
Brno 7
Hebei 7
Stuttgart 7
Taipei 7
Torre Del Greco 7
Acerra 6
Changsha 6
Fairfield 6
Lausanne 6
Mcallen 6
Menlo Park 6
San Giuliano 6
Shanghai 6
Atlanta 5
Groningen 5
Haikou 5
Istanbul 5
Samsun 5
Scafati 5
Toronto 5
Amsterdam 4
Berlin 4
Duncan 4
Ercolano 4
Florence 4
Hangzhou 4
Lanzhou 4
Pontecagnano 4
Salerno 4
Seregno 4
Avellino 3
Casaluce 3
Cava De' Tirreni 3
Chieti 3
Colle di Val d'Elsa 3
Federal 3
Hyderabad 3
Marigliano 3
Mexico 3
Nembro 3
Ningbo 3
Paris 3
Philadelphia 3
Piombino 3
Potenza 3
Quintanar del Rey 3
San Giorgio a Cremano 3
Sarno 3
Totale 7.608
Nome #
Anatomia Patologica dei vasi 107
The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage 92
Impiego di ligandi di natura peptidica e non peptidica del recettore UT dell'Urotensina-II quali marcatori di differenziazione del carcinoma prostatico umano. 92
Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas 81
High levels of GPR30 protein in human testicular carcinoma in situ and seminomas correlate with low levels of estrogen receptor-beta and indicate a switch in estrogen responsiveness 80
Predictive biomarkers along gastric cancer pathogenetic pathways 79
Clinical practice use of liquid biopsy to identify RAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC): A single institution experience 79
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 75
Aurora B Expression in Post-Puberal Testicular Germ Cell Tumours 68
Histopathological pattern of lymph-node metastases from Oral Squamous Cell Carcinoma. An unicentric retrospective study on 146 neck dissections. 66
The role of tissue microarray in the era of target-based agents. 65
c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors 63
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 63
Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung 62
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. 61
Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs. 61
Eighth American Joint Committee on Cancer (AJCC) melanoma classification: what about stage IIC? 61
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment? 60
Adequacy of Cytologic Samples by Ultrasound-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology of Peripheral Pulmonary Nodules for Morphologic Diagnosis and Molecular Evaluations: Comparison With Computed Tomography-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology 60
Parallel determination of NeuroD1, chromogranin-A, KI67 and androgen receptor expression in surgically treated prostate cancers 59
Renal cell carcinoma with solitary toe metastasis 58
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 58
Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer. 57
Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers 57
Concomitant occurrence of facial cutaneous and parotid gland metastases from rectal cancer after preoperative chemoradiotherapy 56
Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma 56
Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas 55
NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension? 54
Deregulation of HOX B13 expression in urinary bladder cancer progression 54
Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome 54
Synchronus primary adenocarcinoma and adenosquamous carcinoma of the esophagus 54
A rare case of malignant solitary fibrous tumor in prostate with review of the literature 54
Detection of High Mobility Group Proteins A1 and A2 represents a valid diagnostic marker in Post-Puberal Testicular Germ Cell Tumors. 53
Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line 53
Activity of gefitinib in a non-small-cell lung cancer patient with both activating and resistance EGFR mutations 53
Kidney Transplant Modifies the Architecture and Microenvironment of Basal Cell Carcinomas 53
The use of ultrasound in detecting and defining ground-glass opacities: results of an ex vivo evaluation 53
A trimodality, four-step treatment including chemotherapy, pleurectomy/decortication and radiotherapy in early-stage malignant pleural mesothelioma: A single-institution retrospective case series study 53
WNT pathway in oral cancer: Epigenetic inactivation of WNT-inhibitors 52
PEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: A tissue-microarray study with clinic-pathological correlations 52
DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck 52
CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. 52
Novel medicinal mushroom blend as a promising supplement in integrative oncology: A multi-tiered study using 4t1 triple-negative mouse breast cancer model 52
HtrA1 loss is related to aggressive behavior parameters in sentinel node positive breast cancer 51
UROTENSIN II RECEPTOR IS INVOLVED IN THE REGULATION OF MOTILITY OF PROSTATE ADENOCARCINOMA CELLS AND PREDICTS THE CLINICAL OUTCOME OF PROSTATE CANCER PATIENTS 51
A new look at the ALK gene in cancer: copy number gain and amplification 51
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC 51
Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy? 51
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 51
ALK Rearrangement in Lung Cancer: Is Patients Filtering Possible 50
Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: Current evidence and future perspectives 50
Skin Adnexal Tumours: A Large Spectrum of Clinic-Pathological Lesions 50
Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways. 49
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. 49
Increased expression and nuclear localization of the centrosomal kinase Nek2 in human testicular seminomas 49
Use of non peptidic and peptidic ligands or immunodetection of the receptor for urotensin II for the definition of both differentiation and prognosis of human prostate adenocrarcinoma 49
A 52-year-old man with a mass in the perineal region. Perineurioma. 49
A case of primary cutaneous B-cell lymphoma with immature features in an old man. Diffuse Large B-cell Lymhpoma with immature features or B-cell Lymhpoblastic Lymphoma? 49
Double-staining Immunohistochemistry Reveals in Malignant Pleural Mesothelioma the Coexpression of ERCC1 and RRM1 as a Frequent Biological Event Related to Poorer Survival 49
Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry 48
Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis 48
Basal Cell Carcinoma: Molecular and Pathological Features 48
Large single cutaneous metastasis of colon adenocarcinoma mimicking a squamous cell carcinoma of the skin: A case report 48
BRAF mutation and RASSF1A expression in thyroid carcinoma of southern Italy 47
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes. 47
Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer 47
Circulating tumor cells as emerging tumor biomarkers in lung cancer. 47
The contrasting role of p16Ink4A patterns of expression in neuroendocrine and non-neuroendocrine lung tumors: A comprehensive analysis with clinicopathologic and molecular correlations 47
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. 46
ESTRADIOL-INDUCED MAP KINASE (ERK1/2) ACTIVITY IN THE FROG (RANA ESCULENTA) TESTIS 46
Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma 46
Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR 46
Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: an unusual clinical coexistence. 45
De novo expression of uncoupling protein 3 is associated to enhanced mitochondrial thioesterase-1 expression and fatty acid metabolism in liver of fenofibrate-treated rats 45
Prostate cancer detection in the "grey area" of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun's nomogram, two risk estimators incorporating prostate cancer antigen 3 45
ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: Results of the first italian external quality assurance scheme 45
Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5 45
Atypical amplification of chromosome region 22q12 in melanoma: A case report 45
TLR4 down-regulation identifies high risk HPV integration in head and neck squamous cell carcinomas 45
Malignant extrapleural solitary fibrous tumor arising in the sublingual gland: A case report and review of literature 45
The potential diagnostic and predictive role of anaplastic lymphoma kinase (ALK) gene alterations in melanocytic tumors 45
Prok1/ProkR1 expression in testis germ cell tumors: study of 90 cases in a tissue micro-array 45
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype 45
EGFR mutational status in penile cancer. 44
Human melanoma metastases express functional CXCR4. 44
CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression 44
SPARC/osteonectin is involved in metastatic process to the lung during melanoma progression 44
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells 44
Aberrant signaling through the HER2-ERK1/2 pathway is predictive of reduced disease-free and overall survival in early stage non-small cell lung cancer (NSCLC) patients 44
Sigmoid metastasis from endometrioid cancer 44
Diagnosis of anaplastic large cell lymphoma on late peri-implant breast seroma: Management of cytological sample by an integrated approach 44
Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples 44
Which treatment after first line therapy in NSCLC patients without genetic alterations in the era of immunotherapy? 44
Differential role of CD133 and CXCR4 in renal cell carcinoma 43
The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. 43
Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution 43
Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma 43
New therapeutic perspectives in CCDC6 deficient lung cancer cells 43
B-cell lymphoblastic lymphoma presenting as solitary temporal mass with amplification of AML1/RUNX1: Case report 43
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study 43
Totale 5.325
Categoria #
all - tutte 58.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.518 302 254 30 26 233 23 304 78 84 82 70 32
2020/20211.984 82 12 260 66 313 25 274 229 69 300 282 72
2021/20222.105 66 36 28 31 702 18 56 71 90 166 195 646
2022/20233.649 490 97 55 260 315 243 10 160 1.875 29 52 63
2023/20241.663 115 60 60 92 607 107 53 93 33 24 107 312
2024/202531 31 0 0 0 0 0 0 0 0 0 0 0
Totale 12.818